Skip to main content

Table 1 Demographic and diagnostic features of the human brain cortical samples used in this study

From: The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer’s disease

  1. Age, gender, post mortem interval (PMI), degree of pathology (Braak stages) and standardized/validated clinical, neuropsychological, neuropathological and behavioral assessments of AD (CERAD) are provided for both control cases (left; non-demented individuals who did not meet pathological diagnostic criteria of AD or any other neurodegenerative diseases), or AD cases (right)
\